Lipocine Inc (LPCN.OQ)
15 Dec 2017
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|57||2014||Chairman of the Board, President, Chief Executive Officer|
|47||2013||Chief Financial Officer, Executive Vice President|
|2017||Executive Vice President, Chief Commercial Officer|
|59||2014||Lead Independent Director|
- BRIEF-Lipocine says FDA assigned a new prescription drug user fee act goal date of May 8, 2018 for Tlando
- BRIEF-Lipocine Inc Q3 loss per share $0.22
- BRIEF-Lipocine says FDA has scheduled bone, reproductive and urologic drugs advisory committee meeting on January 10, 2018
- BRIEF-Lipocine Inc files for mixed shelf of up to $150 million
- BRIEF-Lipocine - PTAB of USPTO issued a motions decision in interference case between Clarus Therapeutics and Lipocine Inc